ResearcherCentre National de la Recherche ScientifiqueNo recent work listed

Michał Antoszczak

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0877-1726; OpenAlex author ID A5032204376. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper

Papers 1

Iron-Sensitive Prodrugs That Trigger Active Ferroptosis in Drug-Tolerant Pancreatic Cancer Cells. Co-author DOI 10.1021/jacs.2c03973 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Raphaël Rodriguez · 1 shared paper, 2022 · strength 0.15
- Paper Iron-Sensitive Prodrugs That Trigger Active Ferroptosis in Drug-Tolerant Pancreatic Cancer Cells. DOI 10.1021/jacs.2c03973 ↗
Patricia Santofimia‐Castaño · 1 shared paper, 2022 · strength 0.15
- Paper Iron-Sensitive Prodrugs That Trigger Active Ferroptosis in Drug-Tolerant Pancreatic Cancer Cells. DOI 10.1021/jacs.2c03973 ↗
Juan Iovanna · 1 shared paper, 2022 · strength 0.15
- Paper Iron-Sensitive Prodrugs That Trigger Active Ferroptosis in Drug-Tolerant Pancreatic Cancer Cells. DOI 10.1021/jacs.2c03973 ↗
Nelson Dusetti · 1 shared paper, 2022 · strength 0.15
- Paper Iron-Sensitive Prodrugs That Trigger Active Ferroptosis in Drug-Tolerant Pancreatic Cancer Cells. DOI 10.1021/jacs.2c03973 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.